Clinical Trials in Phoenix

Showing 2141-2160 of 7,960 trials

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

The purpose of this open-label, multicenter study is to determine the long-term safety, pharmacokinetics and effects of ALK-001 (C20-D3-retinyl acetate) on the progression of Stargardt disease. This study is an extension of NCT02402660 and enrolls participants who are at least 8 years old. Enrollment is by invitation only. Funding Source - FDA OOPD

Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more

Alkeus Pharmaceuticals, Inc.200 participantsStarted Dec 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +5 more locations

RECRUITING< 1 mile

Pulmonary Hemodynamics During Exercise - Research Network

NCT03954574

The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.

Pulmonary Circulation Diseases

Medical University of Graz1,500 participantsStarted Dec 2018

Phoenix, Arizona, United States • Los Angeles, California, United States • Baltimore, Maryland, United States +29 more locations

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Pulmonary Hemodynamics During Exercise - Research Network

Find Trials by Condition in Phoenix

A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Ferric Citrate and Chronic Kidney Disease in Children

A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression

APX005M and Doxorubicin in Advanced Sarcoma

Promoting Early Intervention Timing and Attention to Language

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes